-
Deconstructing Peripheral Neuropathy and Chemo BrainResearchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
-
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
-
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
-
Childhood Cancer Survivors Face Higher Mortality for DecadesAn increased risk of early death exists even after treatment for childhood cancer, but survivors also have the potential for decades of life after cancer.
by Sandra Gordon
-
Building BridgesAACR Scientist↔Survivor Program celebrates 25 years of sparking conversations between cancer patients and researchers.
by Thomas Celona
-
The State of Cancer Care and PregnancyAn expert panel at the AACR Annual Meeting discussed the difficult choices faced when cancer is diagnosed during a pregnancy and how recent laws have brought additional challenges.
by Eric Fitzsimmons
-
Decoding Disparities in Colorectal CancerPeople of African descent who receive genetic testing have fewer actionable mutations compared with white people—suggesting fewer available treatment options.
by Marci A. Landsmann
-
Nudging Our Way to Better Cancer CareResearchers use insights from behavioral economics to encourage taking recommended actions in health care.
by Kevin McLaughlin
-
Post-surgery Option for Liver CancerNew study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Chronic Stress and CancerAccumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
-
AACR Grant Propels Progress in Immunotherapy ResearchA grant from the American Association for Cancer Research (AACR) helped Marco Ruella, MD, develop a new approach to immunotherapy.
-
Self-screening for Cancer: Home Sweet HomeNew cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
